Chronic Obstructive Pulmonary Disease (COPD) affects one in 10 people over the age of 65 and is predicted to be the fifth most common cause of death by 2020. This guide answers questions about its causes, symptoms and principles of treatment.
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
Significantly updated with the latest developments in diagnosis and treatment recommendations, Ferri's Clinical Advisor 2020 features the popular "5 books in 1" format to organize vast amounts of information in a clinically relevant, user-friendly manner. This efficient, intuitive format provides quick access to answers on 1,000 common medical conditions, including diseases and disorders, differential diagnoses, and laboratory tests – all reviewed by experts in key clinical fields. Updated algorithms, along with hundreds of new figures, tables, and boxes, ensure that you stay current with today's medical practice. - Contains significant updates throughout, covering all aspects of current diagnosis and treatment. - Features 27 all-new topics including chronic traumatic encephalopathy, medical marijuana, acute respiratory failure, gallbladder carcinoma, shift work disorder, radial tunnel syndrome, fertility preservation in women, fallopian tube cancer, primary chest wall cancer, large-bowel obstruction, inguinal hernia, and bundle branch block, among others. - Includes a new appendix covering Physician Quality Reporting System (PQRS) Measures. - Provides current ICD-10 insurance billing codes to help expedite insurance reimbursements. - Patient Teaching Guides for many of the diseases and disorders are included, most available in both English and Spanish versions, which can be downloaded and printed for patients.
Most people don't think about breathing; it is an automatic, unconscious act. However, the majority of those with asthma (26 million Americans); chronic obstructive pulmonary disease, or COPD (24 million Americans); or interstitial lung disease (1-2 million Americans) are aware of their shortness of breath because it interferes with work or other daily activities. As a result, these individuals seek medical attention for diagnosis and treatment. Breathe Easy, written by a pulmonologist, explains what constitutes normal breathing, what causes someone to feel short of breath, and what can be done to improve one's breathing. In chapters on asthma, COPD, and interstitial lung disease, Dr. Donald A. Mahler addresses the origins and treatments of these conditions, and offers advice for both standard and alternative therapies to breathe easy. Other chapters describe how we breathe, how to understand respiratory difficulties like chronic shortness of breath, the correct use of inhalers, the effects of aging on the brain and body, and the benefits of exercise. His final chapter provides valuable advice about traveling with oxygen. Illustrated with over fifty enlightening medical graphics, Breathe Easy offers a complete and compact guide for the millions of Americans who are limited by their breathing.
The Pocket Book is for use by doctors nurses and other health workers who are responsible for the care of young children at the first level referral hospitals. This second edition is based on evidence from several WHO updated and published clinical guidelines. It is for use in both inpatient and outpatient care in small hospitals with basic laboratory facilities and essential medicines. In some settings these guidelines can be used in any facilities where sick children are admitted for inpatient care. The Pocket Book is one of a series of documents and tools that support the Integrated Managem.
Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.
This comprehensive, first-of-its kind title is an indispensable resource for pharmacists looking to learn or improve crucial patient assessment skills relevant to all pharmacy practice settings. Pharmacists’ role as health care practitioners is evolving as they are taking a more active part in primary patient care -- helping patients manage their medications and diseases, providing patient education, and, in some jurisdictions, prescribing and adapting medications. To perform their day-to-day duties, pharmacists are best-served using a framework called the patient care process. This framework involves three steps: patient assessment; care plan development and implementation; and monitoring and follow up. Organized in four parts, this practical book begins with introductory chapters regarding the basics of patient assessment and the patient care process. Part II includes a detailed assessment of common symptoms encountered by pharmacists. Part III discusses assessment of patients with various chronic illnesses. Part IV addresses select specialized topics and assessment considerations. An invaluable contribution to the literature, Patient Assessment in Clinical Pharmacy: A Comprehensive Guide will be of great benefit to pharmacists, regardless of their practice setting, and to pharmacy students as well.
This book covers neoplastic and non-neoplastic pulmonary diseases, supplying essential information for the most common pulmonary diseases as well as many of the rarer ones. Organized around disease entities and presented in outline form, this book provides easy access to the essential facts and is illustrated with plentiful figures. The essential pathology, radiology and bronchoscopic technologies are discussed, as well as the tools needed to facilitate the most specific diagnoses and thus the most appropriate therapies. Each chapter also provides a list of suggested readings to guide further study. Written for a broad audience of clinicians who encounter these diseases in their everyday practice, this book serves specialists in pulmonary medicine and internal medicine, as well as general surgical pathologists who encounter these diseases as pulmonary specimens and who use this information for definitive evaluation and diagnoses of these entities, especially in small biopsies and cytopathology specimens. Pulmonary Disease: Pathology, Radiology, Bronchoscopy brings together the essential clinical, radiologic and pathologic insights for the major diseases of the lung, emphasizing the diagnostic criteria needed to ensure accurate diagnoses from small specimens.
A panel of recognized authorities comprehensively review the medical, surgical, and pathophysiologic issues relevant to lung volume reduction surgery for emphysema. Topics range from the open technique and video-assisted thoracoscopic approaches to LVRS, to anesthetic management, to perioperative and nursing care of the patient. The experts also detail the selection of candidates for LVRS, the clinical results and clinical trials in LVRS, and the effects of LVRS on survival rates.